Raptor Pharma Appoints Michael Smith As CFO - Quick Facts

(RTTNews) - Raptor Pharmaceuticals Corp. (RPTP) announced that it has appointed Krishna Polu, M.D., as its Chief Medical Officer and Michael Smith as Chief Financial Officer or CFO, effective January 12, 2015.

Commenting on their roles, the company said that Polu will oversee all global clinical development programs, medical affairs and other related functions and Smith will serve as Raptor's principal financial and accounting officer.

Polu most recently served as Chief Medical Officer at CytomX Therapeutics, a privately-held biotechnology company focused on the development of Probody therapeutics, a novel monoclonal antibody platform for the treatment of cancer, the company said.

Commenting on Michael Smith, Raptor said that most recently he served as Catalyst Biosciences' Chief Financial and Business Advisor.